Microbot Medical Inc.
▲ 1 upgrades / ▼ 0 downgrades / 1 reiterations from 2 firms
Nov 10, 2026 (15 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 23, 2026 | Citizens | initiate | — → Market Outperform | — | 47% |
| Oct 21, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 14, 2026 | B. Riley Securities | reiterate | Buy → Buy | — | 55% |
| Jun 3, 2026 | LUCID CAPITAL MARKETS | initiate | — → Buy | — | 32% |
| Apr 14, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Feb 10, 2026 | B. Riley Securities | initiate | — → Buy | $5 | 55% |
| Dec 3, 2025 | Roth Capital | initiate | — → Buy | $5.5 | 53% |
| Nov 28, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Oct 15, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Sep 11, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $12 | 44% |
| Apr 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Jan 24, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $9 | 44% |
| Jun 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Apr 16, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $7 | 44% |
| Oct 18, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Jun 26, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Jun 6, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $8 | 44% |
| May 9, 2023 | HC Wainwright & Co. | maintain | — → Buy | $8 | 44% |
| Aug 18, 2020 | HC Wainwright & Co. | maintain | — → Buy | $20 | 44% |
| Jan 13, 2020 | HC Wainwright & Co. | reiterate | — → Buy | $26 | 44% |
| Dec 24, 2019 | HC Wainwright & Co. | reiterate | — → Buy | $12 | 44% |
| Jul 22, 2019 | HC Wainwright & Co. | initiate | — → Buy | $10 | 44% |
| Nov 19, 2018 | Ladenburg Thalmann | downgrade | Buy → Neutral | $0 | 45% |
| Jan 31, 2018 | Ladenburg Thalmann | initiate | — → Buy | $1.75 | 45% |
No cross-platform signals in the last 90 days